Open trial of fluoxetine in obsessive-compulsive disorder
- 1 July 1989
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 146 (7) , 909-911
- https://doi.org/10.1176/ajp.146.7.909
Abstract
A 12-week open trial of fluoxetine in 61 obsessive-compulsive disorder patients significantly improved depressive and obsessive-compulsive symptoms. Baseline depression scores were not related to improvement on two obsessive-compulsive scales. The results reinforce the hypothesis of serotonergic abnormalities in obsessive-compulsive disorder.This publication has 9 references indexed in Scilit:
- Serotonin Function in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1988
- Serotonergic Responsivity in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1988
- Fluvoxamine treatment of obsessive-compulsive disorderAmerican Journal of Psychiatry, 1987
- Treatment of severe obsessive-compulsive disorder with fluvoxamineAmerican Journal of Psychiatry, 1987
- An Open Clinical Trial of Fluoxetine in the Treatment of Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 1986
- Fluoxetine Treatment of Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 1985
- FLUOXETINE IN DEPRESSED-PATIENTS - A COMPARISON WITH IMIPRAMINE1984
- Clomipramine Treatment of Obsessive-Compulsive DisorderArchives of General Psychiatry, 1980
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961